<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 21, 1997
Transworld Home HealthCare, Inc.
(Exact name of Registrant as specified in its charter)
New York
(State or other jurisdiction of incorporation)
1-11570 13-3098275
(Commission File Number) (I.R.S. Employer Identification No.)
75 Terminal Avenue, Clark, New Jersey 07066
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (908) 340-1144
(Former name or former address, if changed since last report.)
<PAGE> 2
ITEM 5. OTHER EVENTS.
(a) On April 21, 1997, Transworld Home HealthCare, Inc. (the "Company")
completed the previously announced sale to Hyperion TW Fund L.P. of
4,116,456 shares of the Company's common stock (the "Common Stock") at
a purchase price of $9.875 per share for an aggregate purchase price of
$40,650,000.
(b) On such date, the Company also completed the previously announced sale
to Hyperion Partners II L.P. of 898,877 shares of Common Stock at a
purchase price of $11.125 per share for an aggregate purchase price of
$10,000,000.
(c) Effective May 6, 1997, the Company will change its name to Transworld
HealthCare, Inc. However, the Company's shares of Common Stock will
continue to be quoted on the Nasdaq National Market under the symbol
"TWHH".
-2-
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Transworld Home HealthCare, Inc.
(Registrant)
Date: May 6, 1997 By: /s/ Wayne A. Palladino
-------------------------
Wayne A. Palladino
Senior Vice President and
Chief Financial Officer
-3-
